1. Regulatory T Cells in Autoimmune Hepatitis: Unveiling Their Roles in Mouse Models and Patients
   Han Wang et al, 2020, Front. Immunol. CrossRef
2. Drug Discovery in Liver Disease Using Kinome Profiling
   Bingting Yu et al, 2021, IJMS CrossRef
3. Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis
   Minjie Wan et al, 2021, Front. Med. CrossRef
4. Pathogenesis of autoimmune hepatitis
   Jun-Hua Fan et al, 2021, WJH CrossRef
5. The Defect in Regulatory T Cells in Psoriasis and Therapeutic Approaches
   Naoko Kanda et al, 2021, JCM CrossRef
6. Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors
   Riccardo Mager et al, 2021, CDT CrossRef
7. Celastrol Alleviates Autoimmune Hepatitis Through the PI3K/AKT Signaling Pathway Based on Network Pharmacology and Experiments
   Shuhui Wang et al, 2022, Front. Pharmacol. CrossRef
8. Insights gained from single-cell analysis of immune cells in tofacitinib treatment of Vogt-Koyanagi-Harada disease
   Xiuxing Liu et al, 2022 CrossRef
9. Cognitive Improving Actions of Tofacitinib in a mouse model of Alzheimer disease involving TNF-α, IL-6, PI3K-Akt and GSK-3β signalling pathway
   Songtao Sui et al, 2022, International Journal of Neuroscience CrossRef
10. Autoimmune hepatitis: Towards a personalized treatment
    Alejandro Costaguta et al, 2024, World J Hepatol CrossRef